Metavia logo

Metavia Share Price Today

(NASDAQ: MTVA)

Metavia share price is $1.52 & ₹132.19 as on 6 Mar 2025, 2.30 'hrs' IST

$1.52

0.06

(4.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Metavia share price in Dollar and Rupees. Guide to invest in Metavia stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Metavia, along with analyst recommendations, forecasts, and comprehensive financials.

Metavia share price movements

  • Today's Low: $1.43
    Today's High: $1.59

    Day's Volatility :10.23%

  • 52 Weeks Low: $1.29
    52 Weeks High: $2.75

    52 Weeks Volatility :53.09%

Metavia (MTVA) Returns

PeriodMetavia IncIndex (Russel 2000)
3 Months
-36.52%
0.0%
6 Months
-56.51%
0.0%
1 Year
-73.98%
0.0%
3 Years
-99.16%
-11.6%

Metavia (MTVA) Key Statistics

in dollars & INR

Previous Close
$1.46
Open
$1.4743
Today's High
$1.5897
Today's Low
$1.427
Market Capitalization
$14.4M
Today's Volume
$4.4K
52 Week High
$2.75
52 Week Low
$1.29
Revenue TTM
$0.0
EBITDA
$-28.9M
Earnings Per Share (EPS)
$-4.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-160.76%

How to invest in Metavia Stock (MTVA) from India?

It is very easy for Indian residents to invest directly in Metavia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Metavia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Metavia or MTVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Metavia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Metavia shares which would translate to 0.572 fractional shares of Metavia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Metavia, in just a few clicks!

Returns in Metavia (MTVA) for Indian investors in Rupees

The Metavia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Metavia investment value today

Current value as on today

₹32,057

Returns

₹67,943

(-67.94%)

Returns from Metavia Stock

₹72,906 (-72.91%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Metavia (MTVA)

-46%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Metavia Stock from India on INDmoney has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Metavia

Analyst Forecast on Metavia Stock (MTVA)

What analysts predicted

Upside of 952.63%

Target:

$16.00

Current:

$1.52

Insights on Metavia Stock (Ticker Symbol: MTVA)

  • Price Movement

    In the last 6 months, MTVA stock has moved down by -56.5%
  • MTVA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 139.1%
  • MTVA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.9%

Metavia Technicals Summary

Sell

Neutral

Buy

Metavia is currently in a neutral trading position according to technical analysis indicators.

Metavia (MTVA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Metavia Inc logo
-16.09%
-56.51%
-73.98%
-99.16%
-99.96%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Metavia Inc logo
NA
NA
NA
0.0
-1.61
-0.74
NA
1.51
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Metavia Inc logo
NA
$14.4M
-99.96%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Metavia

MetaVia Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and joint research agreement with Dong-A ST and ImmunoForge for the development of DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts.
Organization
Metavia
Employees
8
CEO
Mr. Heon Kim Hyung
Industry
Miscellaneous

Management People of Metavia

NameTitle
Mr. Heon Kim Hyung
CEO, President & Director
Mr. Marshall H. Woodworth
Chief Financial Officer
Dr. Mi-Kyung Kim
Chief Scientific Officer
Mr. Robert Homolka
Senior Vice President of Clinical Operations
Dr. W. Christopher Fang M.D.
Consulting Chief Medical Officer & Advisor

Important FAQs about investing in MTVA Stock from India :

What is Metavia share price today?

Metavia share price today stands at $1.52, Open: $1.47 ; Previous Close: $1.46 ; High: $1.59 ; Low: $1.43 ; 52 Week High: $2.75 ; 52 Week Low: $1.29.

The stock opens at $1.47, after a previous close of $1.46. The stock reached a daily high of $1.59 and a low of $1.43, with a 52-week high of $2.75 and a 52-week low of $1.29.

Can Indians buy Metavia shares?

Yes, Indians can invest in the Metavia (MTVA) from India.

With INDmoney, you can buy Metavia at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Metavia at zero transaction cost.

How can I buy Metavia shares from India?

It is very easy to buy Metavia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Metavia (MTVA) be purchased?

Yes, you can buy fractional shares of Metavia with INDmoney app.

What are the documents required to start investing in Metavia stocks?

To start investing in Metavia, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Metavia Stock (MTVA)?

Today’s highest price of Metavia (MTVA) is $1.59.

Today’s lowest price of Metavia (MTVA) is $1.43.

What is today's market capitalisation of Metavia?

Today's market capitalisation of Metavia MTVA is 14.4M

What is the 52 Week High and Low Range of Metavia Stock (MTVA)?

  • 52 Week High

    $2.75

  • 52 Week Low

    $1.29

What are the historical returns of Metavia (MTVA)?

  • 1 Month Returns

    -16.09%

  • 3 Months Returns

    -56.51%

  • 1 Year Returns

    -73.98%

  • 5 Years Returns

    -99.96%

Who is the Chief Executive Officer (CEO) of Metavia ?

Mr. Heon Kim Hyung is the current Chief Executive Officer (CEO) of Metavia.